BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22999822)

  • 1. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
    Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
    Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.
    Thériault BL; Basavarajappa HD; Lim H; Pajovic S; Gallie BL; Corson TW
    PLoS One; 2014; 9(3):e91540. PubMed ID: 24626475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP4, a new prognostic factor for glioma.
    Wu Q; Yao J
    World J Surg Oncol; 2013 Oct; 11():264. PubMed ID: 24099560
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ou Y; Luo H; Zhang Q; Du T; Liu R; Wang D; Chen J; Dong M; Wang Y; Yang Z; Wang X
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):144. PubMed ID: 38682183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of Girdin protein expression in glioma.
    Zhao L; Ma S; Liu Q; Liang P
    ScientificWorldJournal; 2013; 2013():986073. PubMed ID: 24288520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of bulk RNA-seq and scRNA-seq data indicates the prognostic and immunologic values of SERPINH1 in glioma.
    Hou S; Chen Y; Jin C; Lin N
    Environ Toxicol; 2024 Jun; 39(6):3654-3665. PubMed ID: 38506564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer.
    Li TF; Zeng HJ; Shan Z; Ye RY; Cheang TY; Zhang YJ; Lu SH; Zhang Q; Shao N; Lin Y
    Cancer Cell Int; 2020; 20():123. PubMed ID: 32322170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
    Han C; Liu S; Ji Y; Hu Y; Zhang J
    Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RFC3 drives the proliferation, migration, invasion and angiogenesis of colorectal cancer cells by binding KIF14.
    Yu R; Wu X; Qian F; Yang Q
    Exp Ther Med; 2024 May; 27(5):222. PubMed ID: 38590579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSPAN6 could serve as a prognostic biomarker for patients with glioma.
    Zeng X; Xie Y; Xie Y; Zhang C
    Asian J Surg; 2024 May; 47(5):2250-2252. PubMed ID: 38403542
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of microRNA-184 in glioma.
    Wu XB; Yang W; Fan G; Lin WR; Liu F; Lu ZM
    Oncol Lett; 2018 Jan; 15(1):727-730. PubMed ID: 29422963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and drug sensitivity of F‑box and leucine‑rich repeat protein 6 in glioma.
    Lin Q; Zhu J; Zhu W; Zhu H; Li M; Zhao J; Jia S; Nie S
    Oncol Lett; 2024 Jul; 28(1):320. PubMed ID: 38807668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin Superfamily Member 18B (KIF18B) Promotes Cell Proliferation in Colon Adenocarcinoma.
    Zhao F; Feng Y; Zhang X; Liu X; Li A
    Cancer Manag Res; 2020; 12():12769-12778. PubMed ID: 33335427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside.
    Zhao K; Li X; Feng Y; Wang J; Yao W
    Biomark Res; 2024 Mar; 12(1):30. PubMed ID: 38433242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer.
    Gerashchenko TS; Zolotaryova SY; Kiselev AM; Tashireva LA; Novikov NM; Krakhmal NV; Cherdyntseva NV; Zavyalova MV; Perelmuter VM; Denisov EV
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
    Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.
    Singel SM; Cornelius C; Zaganjor E; Batten K; Sarode VR; Buckley DL; Peng Y; John GB; Li HC; Sadeghi N; Wright WE; Lum L; Corson TW; Shay JW
    Neoplasia; 2014 Mar; 16(3):247-56, 256.e2. PubMed ID: 24784001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma.
    Hung PF; Hong TM; Hsu YC; Chen HY; Chang YL; Wu CT; Chang GC; Jou YS; Pan SH; Yang PC
    PLoS One; 2013; 8(4):e61664. PubMed ID: 23626713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BUB1/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability.
    Jin T; Ding L; Chen J; Zou X; Xu T; Xuan Z; Wang S; Chen J; Wang W; Zhu C; Zhang Y; Huang P; Pan Z; Ge M
    J Cell Mol Med; 2024 Apr; 28(7):e18182. PubMed ID: 38498903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma.
    Wang H; Tang F; Tang P; Zhang L; Gan Q; Li Y
    Aging (Albany NY); 2022 Oct; 14(19):8013-8031. PubMed ID: 36227151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.